financetom
Business
financetom
/
Business
/
What's Going On With Regencell Bioscience Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Regencell Bioscience Stock Today?
Jun 16, 2025 1:19 PM

Regencell Bioscience Holdings ( RGC ) shares are soaring Monday after the company’s 38-for-one forward stock split officially took effect.

What To Know: The split, announced at the beginning of June and distributed on June 13, gave shareholders 37 additional shares for each one they already owned. The stock began trading on a split-adjusted basis on Monday. The company stated that the goal of the split was to improve liquidity and make its shares more accessible to investors.

Regencell is an early-stage bioscience company based in Hong Kong. The company focuses on developing traditional Chinese medicine treatments for neurological disorders, specifically ADHD and autism spectrum disorder.

The stock split doesn't alter the company's fundamentals or financial outlook. The sharp spike in the company’s share price likely reflects speculative interest following the split. Investors may be reacting to the lower price per share post-split, which can drive short-term volume and volatility.

How To Buy RGC Stock

By now you're likely curious about how to participate in the market for Regencell Bioscience ( RGC ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

RGC Price Action: Regencell Bioscience ( RGC ) shares were up 276.5% at $59.21 at the time of publication Monday, according to Benzinga Pro.

Read Next:

Wall Street Roars Back As Iran Signals De-Escalation: Nasdaq 100 Nears All-Time High

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
WISeKey International Shares Soar; Unit to Launch Satellites With SpaceX in January
WISeKey International Shares Soar; Unit to Launch Satellites With SpaceX in January
Dec 13, 2024
01:56 PM EST, 12/13/2024 (MT Newswires) -- WISeKey International Holdings (WKEY) shares surged 86% in recent Friday trading after the company said its WISeSat.Space subsidiary will launch its next-generation satellites in partnership with SpaceX on Jan. 14 from California's Vandenberg Space Force Base. The satellites are designed to be post-quantum-ready and will use WISeKey's ( WKEY ) security technology and...
Natural Gas Services Files $200 Million Mixed Shelf
Natural Gas Services Files $200 Million Mixed Shelf
Dec 13, 2024
01:56 PM EST, 12/13/2024 (MT Newswires) -- Natural Gas Services Group ( NGS ) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $200 million of its securities from time to time in one or more offerings. The filing covers common and preferred stock, depositary shares, debt securities, rights,...
Update: Market Chatter: Qatar Airways Looking to Remove Boeing 737-10 Model From Order Book
Update: Market Chatter: Qatar Airways Looking to Remove Boeing 737-10 Model From Order Book
Dec 13, 2024
01:56 PM EST, 12/13/2024 (MT Newswires) -- (Updates with Boeing's ( BA ) response in the fifth paragraph.) Boeing's ( BA ) 737-10 model no longer meets the fleet requirements of Qatar Airways and the airline is seeking to remove the aircraft from its order book, Bloomberg reported Friday, citing people familiar with the matter. With an order for 25...
Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump
Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump
Dec 13, 2024
01:53 PM EST, 12/13/2024 (MT Newswires) -- Bicycle Therapeutics ( BCYC ) shares fell more than 31% in recent Friday trading after the company said topline data from a phase 1/2 trial of zelenectide pevedotin combined with Merck's ( MRK ) pembrolizumab showed a 60% overall response rate in first-line metastatic urothelial cancer, in-line with existing therapies. The company said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved